Serina Therapeutics SER
NYSE SER
$1.96 -0.03 (-1.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Serina Therapeutics (SER) Non Operating Investment Income (2021)

Updated

Serina Therapeutics (SER) reported Non Operating Investment Income of $73,000 for FY2023.

Analysis

Serina Therapeutics (SER) Non Operating Investment Income (2021) Analysis & Trends

Dating back to FY2017, Serina Therapeutics' Non Operating Investment Income record includes 4 years.

  • Non Operating Investment Income has a five-year compound annual growth rate of -53.1% (FY2018 to FY2023).
  • According to Business Quant data, Non Operating Investment Income came in at $106,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Serina Therapeutics 32.11 Mn -8.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 106,000.00
API Access

Serina Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=SER&period=max&api_key=YOUR_API_KEY